Successful resection of a giant recurrent gastrointestinal stromal tumour with imatinib mesylate as neoadjuvant therapy

Ji-Ren Yu Department of Gastrointestinal Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, ChinaCorrespondence[email protected]

, MD,

Xiao-Jun Yang Department of Gastrointestinal Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, China

Wei-Li Yang Department of Gastrointestinal Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, China

Yuan Gao Department of Gastrointestinal Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, China

Qing Zhang Department of Gastrointestinal Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, China

References

Wu PC, Langerman A, Ryan CW, Hart J, Swiger S, Posner MC. Surgical treatment of gastrointestinal stromal tumours in the imatinib (STI-571) era. Surgery 2003; 134: 656–65
PubMed Web of Science ®Google Scholar
DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumours: recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231: 51–8
PubMed Web of Science ®Google Scholar
Eisenberg BL, Judson I. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol 2004; 11: 465–75
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Successful resection of a giant recurrent gastrointestinal stromal tumour with imatinib mesylate as neoadjuvant therapy

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Successful resection of a giant recurrent gastrointestinal stromal tumour with imatinib mesylate as neoadjuvant therapy

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date